Corona Vaccination Program Across the Country
The government announced this on Saturday. Initially this vaccine will be given to health workers and front line workers, whose number is 3 crore. In the second phase, more than 50 years of age and in the third phase, people below the age of 50 years who are suffering from serious diseases will be vaccinated. There will be vaccination of about 27 crore people in the second and third phases.
2 vaccines have been approved in the country
Two vaccines have been approved for emergency use in the country. This includes Kovishield of Serum Institute of India (SII) and Kovaxin of Bharat Biotech. In order to deliver both the vaccines to different parts of the country, the government has issued a transport guideline.
What is special about Kovyshield?
Analysis of Coveshield’s clinical trials has yielded very good results. Volunteers first half dose and then full dose. No one has had any serious health problems.Ifficacy was 90% when half dose was given. A month later he was given a full dose. If both full doses were given, the efficency remained at 62%.The average efficency in both types of doses was 70%. All the results are significant in terms of data. Volunteers’ blood samples and immunogenicity tests will be done until one year after the vaccine is administered to find out the efficacy. Samples are being taken every week to check for infection.